PhRMA Foundation President Dr. Amy M. Miller discusses her experience as a rare disease patient and her concerns that policy provisions in the Inflation Reduction Act that could make it less likely for new treatments to reach patients like her.
Jacqueline Plau, a PhD student at Case Western Reserve University and a 2023 PhRMA Foundation Predoctoral Fellow, discusses her career path and research on blinding eye disease.
Kinza Rizwan worked tirelessly to become the first member of her family to graduate high school and attend college. Now a graduate student at Baylor College of Medicine, she has received the PhRMA Foundation’s 2023 Predoctoral Fellowship in Drug Discovery for her research on prostate cancer.
Antibiotics are becoming less effective at treating infections as bacteria adapt and no longer respond to medicines. Foundation awardee Dr. Ashlee Brunaugh of the University of Michigan aims to overcome antimicrobial resistance by developing novel inhaled therapeutics to treat bacterial lung infections. Watch this interview to learn more about her work.
Driving Progress in U.S. Value Assessment
Value assessment is a field of research that seeks to evaluate the relative benefits and costs of health care interventions — such as pharmaceuticals, medical devices, or medical procedures — to ensure health care decisions are guided by the best possible evidence. In a new white paper, the PhRMA Foundation reviews the U.S. value assessment landscape, identifies key challenges, and highlights how Foundation-funded researchers are working toward solutions that will advance the field. Read the paper.
Centers of Excellence in Value Assessment
The Awards
With a wide range of predoctoral and postdoctoral fellowships and research grants, the Foundation offers a myriad of opportunities to advance your career.
Featured Scientist
“Receiving the PhRMA Foundation Predoctoral Fellowship is truly a professional and personal achievement. This support will allow me to continue my efforts in drug discovery research to address the need for novel anti-seizure agents.”
Announcements
Webinar: How to Write a Standout Letter of Intent and Application
What are reviewers looking for when they assess letters of intent and applications for research funding? In this webinar, a former PhRMA Foundation Scientific Advisory Committee member discusses the do’s and don’ts of writing LOIs and grants.
PhRMA Foundation Announces New Members of Board of Directors
The PhRMA Foundation announced the appointment to its Board of Directors of Aida Habtezion, MD, Chief Medical Officer at Pfizer, Maha Radhakrishnan, MD, Chief Medical Officer at Biogen, George Addona, PhD, Senior Vice President and Head of Discovery, Preclinical and Translational Medicine at Merck Research Laboratories, and Lori Reilly, Esq, Chief Operating Officer at PhRMA.
Learn More About PhRMA Foundation Funding Opportunities
The PhRMA Foundation offers a wide variety of research grants, in categories ranging from predoctoral to postdoctoral and spanning several scientific disciplines. Check our awards page to learn more.
See the list of grant opportunities here.
